Rabies vaccine (RabAvert)

BIOLOGICAL3 trials

Sponsors

U.S. Army Medical Research and Development Command, CSL Behring

Conditions

MalariaPlasmodium Falciparum MalariaRabies

Phase 1

FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali

CompletedNCT00349713

U.S. Army Medical Research and Development CommandMalaria, Plasmodium Falciparum Malaria

Start: 2004-11-30End: 2006-12-31Updated: 2017-07-24

Phase I Pediatric FMP2.1/AS02A Trial in Mali

CompletedNCT00358332

U.S. Army Medical Research and Development CommandPlasmodium Falciparum Malaria

Start: 2006-11-30End: 2007-12-31Updated: 2011-10-24

Unknown Phase

Rabies Immune Plasma Booster Study

CompletedNCT01063140

CSL BehringRabies

Start: 2009-01-31End: 2010-05-31Updated: 2015-09-07

Related Papers

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

2010-02-0447 citations